BACKGROUND: Real-time contrast echocardiography (MCE) is a new promising technique for assessing myocardial perfusion. The purpose of this study was to test whether realtime MCE can be used to detect functionally significant coronary artery stenosis in patients with known or suspected coronary artery disease. Myocardial contrast echocardiographic studies were compared with nearly simultaneous 99mTc-sestamibi single photon emission computed tomography (SPECT) as a clinical standard reference to evaluate regional myocardial perfusion defects. METHODS: Real-time MCE based on continuous infusion of Optison (8-10 ml/h) was performed in 66 patients during standard 99mTc-SPECT dipyridamole (0.56 mg/kg x 4 min) stress testing. Images were obtained in apical 4- and 2-chamber views, each divided into 6 segments. Tracer uptake and myocardial opacification were visually analyzed for each segment by two pairs of blinded observers and graded as normal, mildly reduced, severely reduced, or absent. In 792 myocardial segments, myocardial opacification by MCE was uninterpretable in 143 (18%) segments and tracer uptake by SPECT was not clearly defined in 92 (12%) segments. Interobserver variability for MCE was good with concordance rates of 83% (kappa=0.72) for rest- and 86% (kappa=0.76) for stress images. Overall concordance between MCE and SPECT was good (83%, kappa=0.63) at a segmental level. In the diagnosis of fixed and reversible defects, and of normal perfusion, concordance rates were 73, 65 and 83%, respectively. When analysis was performed at the regional level, we found comparable levels of concordance rates for LAD (83%, kappa=0.59), LCX (86%, kappa=0.64) and RCA (80%, kappa=0.68) perfusion territories. CONCLUSIONS: These findings suggest that realtime MCE is a clinically acceptable method to evaluate myocardial perfusion defects during dipyridamole stress testing.
BACKGROUND: Real-time contrast echocardiography (MCE) is a new promising technique for assessing myocardial perfusion. The purpose of this study was to test whether realtime MCE can be used to detect functionally significant coronary artery stenosis in patients with known or suspected coronary artery disease. Myocardial contrast echocardiographic studies were compared with nearly simultaneous 99mTc-sestamibi single photon emission computed tomography (SPECT) as a clinical standard reference to evaluate regional myocardial perfusion defects. METHODS: Real-time MCE based on continuous infusion of Optison (8-10 ml/h) was performed in 66 patients during standard 99mTc-SPECT dipyridamole (0.56 mg/kg x 4 min) stress testing. Images were obtained in apical 4- and 2-chamber views, each divided into 6 segments. Tracer uptake and myocardial opacification were visually analyzed for each segment by two pairs of blinded observers and graded as normal, mildly reduced, severely reduced, or absent. In 792 myocardial segments, myocardial opacification by MCE was uninterpretable in 143 (18%) segments and tracer uptake by SPECT was not clearly defined in 92 (12%) segments. Interobserver variability for MCE was good with concordance rates of 83% (kappa=0.72) for rest- and 86% (kappa=0.76) for stress images. Overall concordance between MCE and SPECT was good (83%, kappa=0.63) at a segmental level. In the diagnosis of fixed and reversible defects, and of normal perfusion, concordance rates were 73, 65 and 83%, respectively. When analysis was performed at the regional level, we found comparable levels of concordance rates for LAD (83%, kappa=0.59), LCX (86%, kappa=0.64) and RCA (80%, kappa=0.68) perfusion territories. CONCLUSIONS: These findings suggest that realtime MCE is a clinically acceptable method to evaluate myocardial perfusion defects during dipyridamole stress testing.
Authors: Mohamed A Oraby; Janet Hays; Fathi A Maklady; Ahmed A El-Hawary; Miguel Zabalgoitia Journal: Am J Cardiol Date: 2002-03-01 Impact factor: 2.778
Authors: S Shimoni; W A Zoghbi; F Xie; D Kricsfeld; S Iskander; L Gobar; I A Mikati; J Abukhalil; M S Verani; E L O'Leary; T R Porter Journal: J Am Coll Cardiol Date: 2001-03-01 Impact factor: 24.094
Authors: S M Badruddin; A Ahmad; J Mickelson; J Abukhalil; W L Winters; S F Nagueh; W A Zoghbi Journal: J Am Coll Cardiol Date: 1999-05 Impact factor: 24.094
Authors: S K Heinle; J Noblin; P Goree-Best; A Mello; G Ravad; S Mull; P Mammen; P A Grayburn Journal: Circulation Date: 2000-07-04 Impact factor: 29.690
Authors: Mohamed A Oraby; Janet Hays; Fathi A Maklady; Ahmed A El-Hawary; Liberty O Yaneza; Miguel Zabalgoitia Journal: Am J Cardiol Date: 2002-09-01 Impact factor: 2.778
Authors: Grigorios Korosoglou; K Gaspar C da Silva; Nino Labadze; Alain-Eric Dubart; Alexander Hansen; Mark Rosenberg; Joerg Zehelein; Helmut Kuecherer Journal: J Am Soc Echocardiogr Date: 2004-01 Impact factor: 5.251